Former HHS Secretary Tom Price joins Georgia governor-elect’s transition team

Amy Baxter | | Health Exec | Management

Tom Price, the former HHS secretary who left the job last year after his controversial use of private jets for official travel, has joined the transition team of Republican Georgia Governor-elect Brian Kemp, The Hill reported.

Price was accused of misusing hundreds of thousands of taxpayer dollars as a result of his travel habits.

According to Kemp, Price will help with policy planning.

“Obviously he's got a lot of great experience with health care,” Kemp told The Hill. “No one is more experienced with legislative matters than Tom Price and certainly his time in D.C. as well, so he's a valuable member of our team, but we're going to continue to work with a lot of different people on healthcare.”

See the full story below:

Ex-health chief Price joins new Georgia governor's transition team

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.